Search

Your search keyword '"Gulizia, Michele Massimo"' showing total 570 results

Search Constraints

Start Over You searched for: Author "Gulizia, Michele Massimo" Remove constraint Author: "Gulizia, Michele Massimo"
570 results on '"Gulizia, Michele Massimo"'

Search Results

101. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)

102. ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes

104. A multidisciplinary consensus document on follow-up strategies for patients treated with percutaneous coronary intervention

105. Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account

106. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?

107. Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey

108. Impact of history of depression on 1-year outcomes in patients with chronic coronary syndromes: An analysis of a contemporary, prospective, nationwide registry

109. Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

110. Erratum to “2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]

111. Inter-company consent document ANMCO / GISE / SICCH: Antithrombotic therapy in patients undergoing surgery and / or interventional heart valve: how to treat complications

112. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper

113. [ANMCO Position paper: Pulmonary circulation diseases and COVID-19]

114. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

115. Supplemental Material, Giubilato_coi_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

116. Supplemental Material, De_Luca_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

117. Supplemental Material, Luca_coi_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

118. Supplemental Material, Colivicchi_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

119. Supplemental Material, Poli_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

120. Supplemental Material, Rao_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

121. Documento di consenso ANMCO/SICI-GISE/SIC/SIECVI/SIRM: Appropriatezza dell’imaging multimodale nelle patologie cardiovascolari [ANMCO/SICI-GISE/SIC/SIECVI/SIRM Consensus document: Appropriateness of multimodality imaging in cardiovascular disease]

122. Supplemental Material, Iorio_disclosure - The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

123. Starting dose and dose adjustment of Non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation

124. External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease

125. Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study

126. Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry

127. Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement

128. Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paper

129. Quantification of Death Risk in Relation to Sex, Pre-Existing Cardiovascular Diseases and Risk Factors in COVID-19 Patients: Let’s Take Stock and See Where We Are

130. ANMCO POSITION PAPER: The role of cardiology in the management of the health needs in the post-Covid-19 era

131. ANMCO POSITION PAPER: Considerations on in-hospital cardiological consultations and cardiology outpatient clinics during the COVID-19 pandemic

132. ANMCO POSITION PAPER: The cardiological clinical activities in the transition phase of the COVID-19 pandemic

133. ANMCO POSITION PAPER: The management of suspect or confirmed COVID-19 patients needing urgent electrophysiology and/or electrostimulation procedures

134. ANMCO POSITION PAPER: Network Organization for the Treatment of Acute Coronary Syndrome Patients during the Emergency COVID-19 Pandemic

135. The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead

136. Pathophysiology and clinical presentation of paediatric heart failure related to congenital heart disease.

137. [ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism]

139. Comparing the Prognostic Impact of Prediabetes with Diabetes in a Nationwide Cohort of Patients with Chronic Coronary Syndromes: An Analysis of the START Registry.

140. Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study

141. Documento di consenso ANMCO/AIAC/SICI-GISE/SIC/SICCH: Chiusura percutanea dell'auricola sinistra in pazienti con fibrillazione atriale non valvolare: Indicazioni, selezione del paziente, competenze e organizzazione e formazione degli operatori

142. Documento di consenso intersocietario ANMCO/ISS/AMD/ANCE/ARCA/FADOI/ GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/ SID/SIF/SIMEU/SIMG/SIMI/SISA Colesterolo e rischio cardiovascolare: percorso diagnostico-terapeutico in Italia

143. Documento di consenso ANMCO/SIC/SICI-GISE/SICCH: Stratificazione del rischio in chirurgia cardiaca e per l'impianto transcatetere di valvola aortica specifico per il paziente anziano

144. Documento di consenso ANMCO/SICP/SIGO: Gravidanza e cardiopatie congenite

145. [ANMCO/SIC/SICI-GISE/SICCH Consensus document: Risk stratification in elderly patients undergoing cardiac surgery and transcatheter aortic valve implantation]

146. Documento di consenso ANMCO/SIC/SICI-GISE/SICCH: Approccio clinico al pretrattamento farmacologico in pazienti candidati a procedure di rivascolarizzazione miocardica

147. Prevenzione cardiovascolare nel cambiamento d’epoca

148. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

149. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

150. Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study

Catalog

Books, media, physical & digital resources